Difficulty: Medium
Average Score: 62%
Practice
A 23-year-old man with HIV infection has Pneumocystis jirovecii pneumoniTherapy is started with trimethoprim-sulfamethoxazole, and his pneumonia resolves. The pharmacotherapy was effective because of inhibition of which of the following?
Correct answer
B
Rationale
Trimethoprim-sulfamethoxazole (TMP-SMX) treats Pneumocystis jirovecii by sequentially inhibiting folate synthesis. Sulfamethoxazole blocks PABA incorporation into folic acid, while trimethoprim inhibits dihydrofolate reductase (B), preventing tetrahydrofolate production essential for DNA synthesis in the pathogen. Cell wall synthesis is targeted by beta-lactams, not TMP-SMX. PABA incorporation is inhibited by sulfamethoxazole, but the question emphasizes the final effective step. Sterol incorporation relates to antifungals like amphotericin, and topoisomerase II (E) to quinolones.